In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids

Neglected Tropical Diseases (NTDs), like leishmaniasis, are major causes of mortality in resource-limited countries. The mortality associated with these diseases is largely due to fragile healthcare systems, lack of access to medicines, and resistance by the parasites to the few available drugs. Man...

Full description

Bibliographic Details
Main Authors: Ifedayo Victor Ogungbe, William N. Setzer
Format: Article
Language:English
Published: MDPI AG 2013-07-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/18/7/7761
_version_ 1818179871249006592
author Ifedayo Victor Ogungbe
William N. Setzer
author_facet Ifedayo Victor Ogungbe
William N. Setzer
author_sort Ifedayo Victor Ogungbe
collection DOAJ
description Neglected Tropical Diseases (NTDs), like leishmaniasis, are major causes of mortality in resource-limited countries. The mortality associated with these diseases is largely due to fragile healthcare systems, lack of access to medicines, and resistance by the parasites to the few available drugs. Many antiparasitic plant-derived isoprenoids have been reported, and many of them have good in vitro activity against various forms of Leishmania spp. In this work, potential Leishmania biochemical targets of antiparasitic isoprenoids were studied in silico. Antiparasitic monoterpenoids selectively docked to L. infantum nicotinamidase, L. major uridine diphosphate-glucose pyrophosphorylase and methionyl t-RNA synthetase. The two protein targets selectively targeted by germacranolide sesquiterpenoids were L. major methionyl t-RNA synthetase and dihydroorotate dehydrogenase. Diterpenoids generally favored docking to L. mexicana glycerol-3-phosphate dehydrogenase. Limonoids also showed some selectivity for L. mexicana glycerol-3-phosphate dehydrogenase and L. major dihydroorotate dehydrogenase while withanolides docked more selectively with L. major uridine diphosphate-glucose pyrophosphorylase. The selectivity of the different classes of antiparasitic compounds for the protein targets considered in this work can be explored in fragment- and/or structure-based drug design towards the development of leads for new antileishmanial drugs.
first_indexed 2024-12-11T21:10:45Z
format Article
id doaj.art-2bd73c8f95c34b0396a07a5c77b7234d
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-12-11T21:10:45Z
publishDate 2013-07-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-2bd73c8f95c34b0396a07a5c77b7234d2022-12-22T00:50:44ZengMDPI AGMolecules1420-30492013-07-011877761784710.3390/molecules18077761In-silico Leishmania Target Selectivity of Antiparasitic TerpenoidsIfedayo Victor OgungbeWilliam N. SetzerNeglected Tropical Diseases (NTDs), like leishmaniasis, are major causes of mortality in resource-limited countries. The mortality associated with these diseases is largely due to fragile healthcare systems, lack of access to medicines, and resistance by the parasites to the few available drugs. Many antiparasitic plant-derived isoprenoids have been reported, and many of them have good in vitro activity against various forms of Leishmania spp. In this work, potential Leishmania biochemical targets of antiparasitic isoprenoids were studied in silico. Antiparasitic monoterpenoids selectively docked to L. infantum nicotinamidase, L. major uridine diphosphate-glucose pyrophosphorylase and methionyl t-RNA synthetase. The two protein targets selectively targeted by germacranolide sesquiterpenoids were L. major methionyl t-RNA synthetase and dihydroorotate dehydrogenase. Diterpenoids generally favored docking to L. mexicana glycerol-3-phosphate dehydrogenase. Limonoids also showed some selectivity for L. mexicana glycerol-3-phosphate dehydrogenase and L. major dihydroorotate dehydrogenase while withanolides docked more selectively with L. major uridine diphosphate-glucose pyrophosphorylase. The selectivity of the different classes of antiparasitic compounds for the protein targets considered in this work can be explored in fragment- and/or structure-based drug design towards the development of leads for new antileishmanial drugs.http://www.mdpi.com/1420-3049/18/7/7761antileishmanial activityterpenoidsdrug targetsdockingLeishmania
spellingShingle Ifedayo Victor Ogungbe
William N. Setzer
In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids
Molecules
antileishmanial activity
terpenoids
drug targets
docking
Leishmania
title In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids
title_full In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids
title_fullStr In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids
title_full_unstemmed In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids
title_short In-silico Leishmania Target Selectivity of Antiparasitic Terpenoids
title_sort in silico leishmania target selectivity of antiparasitic terpenoids
topic antileishmanial activity
terpenoids
drug targets
docking
Leishmania
url http://www.mdpi.com/1420-3049/18/7/7761
work_keys_str_mv AT ifedayovictorogungbe insilicoleishmaniatargetselectivityofantiparasiticterpenoids
AT williamnsetzer insilicoleishmaniatargetselectivityofantiparasiticterpenoids